We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current 0RIM market cap is 145.41M. The company's latest EPS is EUR -0.5984 and P/E is -0.85.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 4.35M | 4.91M | 7.72M | 7.71M | 4.87M |
| Operating Income | -33.04M | -30.3M | -24.93M | -28.13M | -27.84M |
| Net Income | -33.45M | -30.87M | -34.02M | -28.62M | -27.63M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 36.98M | 32.48M | 47.36M | 56.65M | 25.94M |
| Total Liabilities | 13.11M | 21.97M | 35.69M | 40.66M | 41.22M |
| Total Equity | 23.87M | 10.52M | 11.67M | 15.99M | -15.28M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -28.38M | -28.11M | -15.04M | -17.14M | -33.75M |
| Investing | -663k | -102k | -376k | -16k | 172k |
| Financing | -115k | 21.25M | 33.86M | 23.74M | 96k |
| Market Cap | 145.41M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 4.84 |
| Price to Cash Ratio | 2.22 |
| Price to Book Ratio | -1.54 |
| Dividend Yield | - |
| Shares Outstanding | 46.16M |
| Average Volume (1 week) | 1.13k |
| Average Volume (1 Month) | 3.55k |
| 52 Week Change | 0.0% |
| 52 Week High | 3.15 |
| 52 Week Low | 3.15 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Gensight Biologics Sa |
| Address |
74, rue du faubourg saint-antoine paris, paris 75012 |
| Website | https://www.gensight-biologics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
